The Ottawa Hospital’s Biotherapeutics Manufacturing Centre is building the future of medicine
Making cutting-edge therapies and world-changing vaccines in the most successful facility of its kind in Canada
Our state-of-the-art Biotherapeutics Manufacturing Centre (BMC) is a leader in the rapidly growing field of biotherapeutics — one of the most cutting-edge areas of medical innovation.
We’re using stem cells, cancer-killing viruses, gene therapy, and more, to improve and save lives. We’ve also manufactured more than 15 different cell- and virus-based living drugs for human clinical trials conducted in 11 different countries.
We’re the only hospital-based facility in Canada that has widely produced both cell- and virus-based therapies, and in the ongoing global fight against COVID-19, The Ottawa Hospital helped fill Canada’s critical needs in vaccine manufacturing for clinical trials.
The innovations taking place at the BMC are making a real difference in the lives of people right here in Ottawa.
Success stories from our BMC
There is no other facility in Canada doing what we do. The BMC offers end-to-end manufacturing solutions to academic and industrial partners around the world, done according to the highest standard of good manufacturing practices. We also founded CanPRIME, the only hands-on biomanufacturing training program in Canada.
As an integral part of Canada’s growing biomanufacturing ecosystem, we’re creating the future of medicine here at The Ottawa Hospital, every day.
Opened in 2006
40 highly skilled staff
8 product suites
15+ different cells and viruses manufactured
11 countries where our products have been used